| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |